Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging

NCT01436604 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped lack of recruitment

Conditions

Cancer, Breast
LV Dysfunction

Interventions

OTHER: Cardiac MRI

Sponsor

Centre Francois Baclesse